Allgens Medical Technology (688613.SH) products have obtained registration certificates in Thailand.
Ouji Medical (688613.SH) announced that in May 2025, the company submitted an application for the registration of its artificial bone repair materials to the Food and Drug Administration of Thailand (TFDA). The company recently received notification from the TFDA that its artificial bone repair materials have been approved.
Allgens Medical Technology (688613.SH) announced that in May 2025, the company submitted the registration application materials for its artificial bone repair materials to the Thailand Food and Drug Administration (TFDA). The company recently received notification from the TFDA that its artificial bone repair materials have been approved.
Obtaining registration for the company's products in Thailand is an important part of the company's overseas business expansion, and will play a role in promoting and accelerating the sale of the company's products overseas.
Related Articles
On April 10, KUNLUN ENERGY (00135) spent HK$5.1574 million to repurchase 696,000 shares.
NOAH HOLDINGS (06686) spent $242,400 to repurchase 121,200 shares on April 9th.
CARRIANNA (00126): Ma Hongming appointed as a non-executive director.
On April 10, KUNLUN ENERGY (00135) spent HK$5.1574 million to repurchase 696,000 shares.
NOAH HOLDINGS (06686) spent $242,400 to repurchase 121,200 shares on April 9th.
CARRIANNA (00126): Ma Hongming appointed as a non-executive director.
RECOMMEND
